VIP and acute respiratory distress syndrome: We have reported intervention factors such as a COX-2/sEH dual inhibitor, vasoactive intestinal peptide (VIP), and epoxyeicosatrienoic acids could attenuate ALI by inhibiting the NLRP3 inflammasome activation in mice 3, 11, 12.